poloxalene has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Fang, Q; Tang, R; Wang, J; Wang, X; Zeng, X; Zheng, Y | 1 |
| Alakhov, VY; Gebhart, C; Kabanov, A; Sriadibhatla, S; Yang, Z | 1 |
2 other study(ies) available for poloxalene and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen-Ion Concentration; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Micelles; Molecular Structure; Oxidative Stress; Particle Size; Poloxalene; Surface Properties; Tumor Cells, Cultured | 2020 |
Transcriptional activation of gene expression by pluronic block copolymers in stably and transiently transfected cells.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Luciferases; Mammary Neoplasms, Experimental; Maximum Tolerated Dose; Mice; Microscopy, Confocal; Myoblasts; NIH 3T3 Cells; Poloxalene; RNA, Messenger; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 2006 |